Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia - Scorecard - MDSpire
Advertisement
Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia
Clinical Scorecard: Nutritional Status Changes During Induction Chemotherapy and Their Impact on Treatment Outcomes in Pediatric Acute Myeloid Leukemia Patients
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Children with newly diagnosed AML aged 0–18 years, specifically focusing on those undergoing induction chemotherapy.
Care Setting
Key Highlights
Weight Z-score decline > 1.0 is an independent risk factor for poor treatment outcomes.
Severe weight Z-score decline correlates with lower remission rates and higher TRM.
Dynamic monitoring of nutritional indicators provides insights into treatment-related complications.
Serum albumin decline > 10 g/L is also a significant predictor of treatment outcomes.
Guideline-Based Recommendations
Diagnosis
Management
Standard induction chemotherapy protocols based on NCCN Guidelines for Pediatric AML, including specific regimens.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Nutritional status changes significantly impact treatment outcomes, necessitating early nutritional intervention; findings are based on a cohort of 62 pediatric patients.
Clinical Best Practices
Implement dynamic nutritional monitoring during induction chemotherapy.
Initiate nutritional support by the end of chemotherapy based on weight Z-score decline, ideally within 1 week post-chemotherapy.
